Literature DB >> 11423190

Clostridium perfringens beta toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis.

R K Tweten1.   

Abstract

The Clostridium septicum alpha toxin and the Clostridium perfringens beta toxin are examples of pore-forming toxins that exhibit several different features. The cell types that are targeted by these toxins reflect the effect these toxins have on the host during infection with either organism. Alpha toxin elicits a rapid shock-like syndrome, whereas beta toxin appears to induce a variety of neurological effects. The effects of the purified toxins appear to mimic some of the features of the animal and human diseases caused by C. septicum and C. perfringens. This review, examines the current state of knowledge for the cytolytic mechanism, role in pathogenesis and structure of these two toxins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423190     DOI: 10.1016/s0378-1135(01)00372-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  15 in total

1.  Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins.

Authors:  Masahiro Nagahama; Akiko Ohkubo; Masataka Oda; Keiko Kobayashi; Katsuhiko Amimoto; Kazuaki Miyamoto; Jun Sakurai
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

2.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

Review 3.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

4.  The p38 MAPK and JNK pathways protect host cells against Clostridium perfringens beta-toxin.

Authors:  Masahiro Nagahama; Masahiro Shibutani; Soshi Seike; Mami Yonezaki; Teruhisa Takagishi; Masataka Oda; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2013-07-22       Impact factor: 3.441

5.  Involvement of tumour necrosis factor-alpha in Clostridium perfringens beta-toxin-induced plasma extravasation in mice.

Authors:  M Nagahama; A Kihara; H Kintoh; M Oda; J Sakurai
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

6.  The pore-forming α-toxin from clostridium septicum activates the MAPK pathway in a Ras-c-Raf-dependent and independent manner.

Authors:  Anjana Chakravorty; Milena M Awad; Jackie K Cheung; Thomas J Hiscox; Dena Lyras; Julian I Rood
Journal:  Toxins (Basel)       Date:  2015-02-10       Impact factor: 4.546

7.  Identification of glutamate ABC-Transporter component in Clostridium perfringens as a putative drug target.

Authors:  Bharti Bhatia; Sanket Singh Ponia; Amit Kumar Solanki; Aparna Dixit; Lalit C Garg
Journal:  Bioinformation       Date:  2014-07-22

8.  Programmed cellular necrosis mediated by the pore-forming alpha-toxin from Clostridium septicum.

Authors:  Catherine L Kennedy; Danielle J Smith; Dena Lyras; Anjana Chakravorty; Julian I Rood
Journal:  PLoS Pathog       Date:  2009-07-17       Impact factor: 6.823

9.  Clostridium septicum Empyema in an Immunocompetent Woman.

Authors:  Alexander B Granok; Patrick A Mahon; Genesio W Biesek
Journal:  Case Rep Med       Date:  2010-05-16

10.  Molecular and cellular basis of microvascular perfusion deficits induced by Clostridium perfringens and Clostridium septicum.

Authors:  Michael J Hickey; Rain Y Q Kwan; Milena M Awad; Catherine L Kennedy; Lauren F Young; Pam Hall; Leanne M Cordner; Dena Lyras; John J Emmins; Julian I Rood
Journal:  PLoS Pathog       Date:  2008-04-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.